Other genes hypomethylated and overexpressed in PTCL—RAB13, MPZL1, CDK14—were implicated in tumor progression of several different tumors including B-cell lymphomas, and glioblastomas, lung and ovarian [34,35,46,47]. The gene discussed is CDK14; the disease is glioblastoma.